About Gelesis
We take our cues from nature to mimic the physical properties of vegetables. We’re developing biomimetic hydrogel therapies for obesity and other chronic metabolic diseases.
In April 2019, Gelesis received FDA clearance for its lead product candidate, Plenity®, as an aid for weight management in overweight and obese adults with a Body Mass Index (BMI) of 25-40 kg/m², when used in conjunction with diet and exercise. Plenity is contraindicated in patients who are pregnant or are allergic to cellulose, citric acid, sodium stearyl fumarate, gelatin, or titanium dioxide. The most common side effects were diarrhea, distended abdomen, infrequent bowel movements, and flatulence. Plenity is currently available in limited release in the U.S.
Gelesis’ proprietary approach inspired to structurally mimic vegetables is designed to act mechanically in the GI pathway to potentially alter the course of certain chronic diseases. In addition to Plenity, Gelesis is developing additional investigational candidates such as Gelesis200, a hydrogel optimized for weight loss and glycemic control in patients with type 2 diabetes and prediabetes. This biomimetic hydrogel based on the Gelesis platform technology are also being advanced in other GI inflammatory conditions, such as non-alcoholic steatohepatitis (NASH) and functional constipation.
Community guidelines: http://bit.ly/2Q8VfUG
|
|
|
11-50 employees
View all Gelesis employees
|
|
Biotechnology
|
|
501 Boylston St, Suite 6102, Boston, MA 02116, US
|
|
2006
|
|
Diabetes, Medical Devices, Obesity, Obesity, Medical Devices, Diabétes
|
Gelesis Alternatives
Frequently Asked Questions about Gelesis
Yishai Zohar is the CEO of Gelesis. To contact Yishai Zohar email at [email protected]. Or you may call +1.6173314188 or +1.6174822333
The decision makers in Gelesis are Carla Melcarne, Cosimo Saponaro, Derek Cutler, etc. Click to Find Gelesis decision makers emails.
You can reach Gelesis by visiting their website and using the 'Contact Us' form. Alternatively, you can email them directly at their customer service address provided on the site for any product-related inquiries or support.
Gelesis does not publicly provide a detailed staff directory. However, you can find key leadership team members and their roles on the company’s website under the 'About Us' section, which highlights their expertise in obesity and metabolic disease solutions.
Gelesis primarily focuses on the healthcare industry, particularly in obesity management and chronic metabolic diseases. Their innovative biomimetic hydrogel therapies are designed to support patients and healthcare providers in addressing these significant health challenges.
Yes, detailed information about Plenity®, including its benefits and usage, can be found on Gelesis's official website. For specific questions or personalized inquiries, you can also contact their customer support team through the contact options provided.
Gelesis offers a range of support for healthcare professionals, including educational resources, product information, and clinical data on their therapies. For more specific inquiries, professionals can contact Gelesis directly through their website.
Gelesis ensures the safety and efficacy of its products through rigorous clinical trials and adherence to FDA regulations. Their lead product, Plenity®, received FDA clearance, demonstrating their commitment to high standards in product development and patient care.
Gelesis Staff Directory
Search Gelesis Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
